These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10334376)

  • 41. Safety pharmacology of acute LSD administration in healthy subjects.
    Holze F; Caluori TV; Vizeli P; Liechti ME
    Psychopharmacology (Berl); 2022 Jun; 239(6):1893-1905. PubMed ID: 34515824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cluster of lysergic acid diethylamide (LSD) poisonings following insufflation of a white powder sold as cocaine.
    Roberts DM; Premachandra KH; Chan BS; Auld R; Jiranantakan T; Ewers C; McDonald C; Shaw V; Brown JA
    Clin Toxicol (Phila); 2021 Nov; 59(11):969-974. PubMed ID: 33849370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.
    Dolder PC; Schmid Y; Haschke M; Rentsch KM; Liechti ME
    Int J Neuropsychopharmacol; 2015 Jun; 19(1):. PubMed ID: 26108222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Visual disturbances experienced by hallucinogenic drug abusers while driving.
    Woody GE
    Am J Psychiatry; 1970 Nov; 127(5):683-6. PubMed ID: 5491546
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute LSD effects on response inhibition neural networks.
    Schmidt A; Müller F; Lenz C; Dolder PC; Schmid Y; Zanchi D; Lang UE; Liechti ME; Borgwardt S
    Psychol Med; 2018 Jul; 48(9):1464-1473. PubMed ID: 28967351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bad drug trips and flashbacks.
    Juve JL
    Child Welfare; 1972 Jan; 51(1):41-50. PubMed ID: 5077498
    [No Abstract]   [Full Text] [Related]  

  • 47. Variable adverse effects in subjects after ingestion of equal doses of Argyreia nervosa seeds.
    Kremer C; Paulke A; Wunder C; Toennes SW
    Forensic Sci Int; 2012 Jan; 214(1-3):e6-8. PubMed ID: 21803515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study.
    Lerner AG; Gelkopf M; Oyffe I; Finkel B; Katz S; Sigal M; Weizman A
    Int Clin Psychopharmacol; 2000 Jan; 15(1):35-7. PubMed ID: 10836284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An analysis of psychedelic drug flashbacks.
    Wesson DR; Smith DE
    Am J Drug Alcohol Abuse; 1976; 3(3):425-38. PubMed ID: 1032755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of alcoholism using psychedelic drugs: a review of the program of research.
    Mangini M
    J Psychoactive Drugs; 1998; 30(4):381-418. PubMed ID: 9924844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects.
    Mueller F; Lenz C; Dolder PC; Harder S; Schmid Y; Lang UE; Liechti ME; Borgwardt S
    Transl Psychiatry; 2017 Apr; 7(4):e1084. PubMed ID: 28375205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drug consumption in young persons. Comparative study in relation to sex].
    Biener K
    Minerva Med; 1974 Jul; 65(54):2908-15. PubMed ID: 4843562
    [No Abstract]   [Full Text] [Related]  

  • 53. LSD.
    Med Lett Drugs Ther; 1967 Jan; 9(1):1-2. PubMed ID: 6040593
    [No Abstract]   [Full Text] [Related]  

  • 54. Psychedelic therapy utilizing LSD in the treatment of the alcoholic patient: a preliminary report.
    Kurland AA; Unger S; Shaffer JW; Savage C
    Am J Psychiatry; 1967 Apr; 123(10):1202-9. PubMed ID: 4381477
    [No Abstract]   [Full Text] [Related]  

  • 55. Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features.
    Lerner AG; Gelkopf M; Skladman I; Rudinski D; Nachshon H; Bleich A
    Int Clin Psychopharmacol; 2003 Mar; 18(2):101-5. PubMed ID: 12598822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stable quantitative EEG difference in post-LSD visual disorder by split-half analysis: evidence for disinhibition.
    Abraham HD; Duffy FH
    Psychiatry Res; 1996 Oct; 67(3):173-87. PubMed ID: 8912957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series.
    Karst M; Halpern JH; Bernateck M; Passie T
    Cephalalgia; 2010 Sep; 30(9):1140-4. PubMed ID: 20713566
    [No Abstract]   [Full Text] [Related]  

  • 58. The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta-analysis of randomised controlled trials in healthy volunteers.
    Li H; Zhong Y; Yang S; Wang J; Li X; Xu J; Gao H; Chen G
    Hum Psychopharmacol; 2022 May; 37(3):e2825. PubMed ID: 34739739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistent afterimages (palinopsia) and photophobia in a patient with a history of LSD use.
    Sunness JS
    Retina; 2004 Oct; 24(5):805. PubMed ID: 15492641
    [No Abstract]   [Full Text] [Related]  

  • 60. Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile.
    Coney LD; Maier LJ; Ferris JA; Winstock AR; Barratt MJ
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28517366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.